首页 >>2020年02期
中国1978年后出生健康人群破伤风抗体保护率Meta分析
作者:刘斯 王传林 王洪波 刘珵 李雪迎 熊辉

摘要:

目的  对中国1978年后出生的健康人群破伤风抗体保护率进行Meta分析。方法  检索中国知网、万方数据知识服务平台、维普期刊资源整合服务平台、中国生物医学文献服务系统、PubMed英文数据库和The Cochrane Library中公开发表的中国(不含中国香港、澳门和台湾数据)破伤风抗体水平的研究文献,中文检索主题词为"破伤风抗毒素""破伤风抗体""健康人群""中国内地",英文检索词包括"tetanus antitoxin""tetanus vaccine""tetanus vaccination""general population""mainland of china",纳入文献研究时限为2010—2019年,采用Stata软件对破伤风抗体保护率进行Meta分析。结果  共纳入24篇文献,总调查人数为23 530名,抗体保护率为49.5%~99.0%。抗体≥0.1 IU/ml为达到保护水平,共20 817名,破伤风抗体合并保护率为78.6%(95%CI:75.0%~88.2%)。0~7和8~15岁组抗体合并保护率分别是88.9%(95%CI:86.9%~91.0%)和79.3%(95%CI:72.9%~86.2%);16~20、21~30和31~40岁组抗体合并保护率分别为58.9%(95%CI:46.5%~71.2%)、47.7%(95%CI:16.8%~78.7%)和63.8%(95%CI:32.6%~95.1%);0~15岁组破伤风抗体的合并保护率为85.6%(95%CI:83.1%~88.1%),16~40岁组抗体的合并保护率为52.9%(95%CI:39.3%~66.6%)。结论  随着年龄增长,我国16~40岁健康人群破伤风抗体保护率下降,应根据既往破伤风疫苗接种史,必要时根据破伤风抗体水平,制定个体化的疫苗接种方案。

关键词:破伤风;抗体;保护率;Meta分析

Abstract:

Objective  Meta-analysis was conducted on the tetanus antibody protection rate of healthy population born after 1978 in China (data from Hong Kong, Macao and Taiwan was excluded, the same below).Methods  Search the data on China′s tetanus antibody level which were published in China National Knowledge Infrastructure, Wanfang data, VIP, SinoMed database, PubMed and the Cochrane Library. The Chinese search keywords were "Tetanus Antitoxin", "Tetanus Antibody", "Healthy Population" and "Mainland China". English search terms include "tetanus antitoxin", "tetanus vaccine", "tetanus vaccine", "general population" and "mainland of China". The time limit for inclusion in literature research was 2010-2019. Stata software was used to conduct meta-analysis on the protection rate of tetanus antibody.Results  A total of 24 articles were included. There was no obvious publication bias in the included articles. The total number of respondents was 23 530, the antibody protection rate was 49.5%-99.0%. A total of 20 817 people got effective antibody protection, which meant the antibody level reached and exceeded 0.1 IU/ml, and the combined protection rate was 78.6% (95%CI: 75.0%-88.2%). The combined protection rates of antibody in 0-7 years old and 8-15 years old groups were 88.9% (95%CI: 86.9%-91.0%) and 79.3% (95%CI: 72.9%-86.2%) respectively. The combined protection rates of antibodies in 16-20 years old, 21-30 years old and 31-40 years old groups were 58.9% (95%CI: 46.5%-71.2%), 47.7% (95%CI: 16.8%-78.7%) and 63.8% (95%CI:32.6%-95.1%) respectively. The combined protection rate of tetanus antibody for 0-15 years old people was 85.6% (95%CI: 83.1%-88.1%), and the combined protection rate of antibody for 16-40 years old people was 52.9% (95%CI: 39.3%-66.6%).Conclusion  With the increase of age, the protection rate of tetanus antibody among the healthy population aged 16-40 years in our country decreases. An individualized vaccination plan should be formulated according to the previous tetanus vaccination history and the tetanus antibody level when necessary.

Key words: Tetanus;Antibodies;Protection rate;Meta-analysis

发表日期:2020/2

引用本文:

图/表:

  • 10.3760/cma.j.issn.0253-9624.2020.02.017.T001:表1 文献质量评价标准[3]

    10.3760/cma.j.issn.0253-9624.2020.02.017.T001:表1 文献质量评价标准[3]

  • 10.3760/cma.j.issn.0253-9624.2020.02.017.T002:表2 纳入文献的基本特征

    10.3760/cma.j.issn.0253-9624.2020.02.017.T002:表2 纳入文献的基本特征

  • 10.3760/cma.j.issn.0253-9624.2020.02.017.F001:图1 2010—2019年中国破伤风总保护率Meta分析森林图

    10.3760/cma.j.issn.0253-9624.2020.02.017.F001:图1 2010—2019年中国破伤风总保护率Meta分析森林图

  • 10.3760/cma.j.issn.0253-9624.2020.02.017.F002:图2 2010—2019年中国破伤风总保护率漏斗图

    10.3760/cma.j.issn.0253-9624.2020.02.017.F002:图2 2010—2019年中国破伤风总保护率漏斗图

  • 10.3760/cma.j.issn.0253-9624.2020.02.017.T003:表3 2010—2019年中国不同特征人群破伤风抗体保护率分析

    10.3760/cma.j.issn.0253-9624.2020.02.017.T003:表3 2010—2019年中国不同特征人群破伤风抗体保护率分析

参考文献:

[1]Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases [M]. 10th ed. Washington: Public Health Foundation,2008:273-282.
[2]SanfordJP. Tetanus-forgotten but not gone[J]. N Engl J Med, 1995,332(12):812-813.
[3]KhambaliaAZ, SeenLS. Trends in overweight and obese adults in Malaysia(1996-2009): a systematic review[J]. Obes Rev, 2010,11(6):403-412. DOI: 10.1111/j.1467-789X.2010.00728.x.
[4]HigginsJP, ThompsonSG, DeeksJJ, et al. Measuring inconsistency in Meta-analyses[J].BMJ, 2003,327(7414):557-560. DOI: 10.1136/bmj.327.7414.557.
[5]邢启明,苏宁,吴德平.广州市番禺区2014年健康人群麻疹、风疹、破伤风、水痘的抗体水平监测[J].医学动物防制,2016,32(7):723-725, 728.
[6]刘倩,丰达星,赵升,等.河南省健康人群百日咳、白喉、破伤风抗体水平分析[J].当代医学,2013,(31):160-161. DOI: 10.3969/j.issn.1009-4393.2013.31.124.
[7]从克,赵鸣,郭沙沙. 2015年许昌市部分健康人群百日咳、白喉、破伤风抗体水平及免疫成功率监测[J].预防医学论坛,2016,22(10):787-788, 790.
[8]孙文,鲁晓伍,项庆军,等.健康献浆员破伤风抗体水平调查分析[J].中国生物制品学杂志,2014,27(6):822-824.
[9]罗君,朱路平,李东丽.酶联免疫吸附试验法检测基础免疫儿童破伤风抗体水平[J].中国全科医学,2012,15(18):2118-2119. DOI: 10.3969/j.issn.1007-9572.2012.06.115.
[10]张震文,茌静,雷蕾,等.深圳市宝安区健康人群百日咳、白喉、破伤风抗体水平监测[J].热带医学杂志,2012,12(8):1028-1030.
[11]刘新利,李跟平,王云婕,等.陕西省铜川市健康人群百日咳、白喉、破伤风抗体水平监测结果分析[J].疾病监测,2012,27(7): 516-519. DOI: 10.3784/j.issn.1003-9961.2012.7.005.
[12]喻同琦,占建波,徐胜平,等. 2011年湖北省麻城市健康人群百日咳、白喉、破伤风抗体水平调查[J].实用预防医学,2012,19(11):1644-1645. DOI: 10.3969/j.issn.1006-3110.2012.11.013.
[13]刘洁. 2010年白山市健康人群百日咳、白喉及破伤风IgG抗体水平监测[J].现代预防医学,2012,39(7):1781-1782.
[14]曾德秀,杨芳,向鑫,等.荆州区2012年儿童麻疹、脊髓灰质炎、乙型脑炎、破伤风抗体水平调查[J].中国当代医药,2013,20(3):175-176,178. DOI: 10.3969/j.issn.1674-4721.2013.03.087.
[15]姜占元.海西州2010年—2012年健康人群抗体水平监测分析[J].青海医药杂志,2013,43(6):50-52.
[16]何凌,向平,周玲.宜昌市508例健康人群百白破抗体水平监测分析[J].公共卫生与预防医学,2013,24(2):92-93.
[17]赵义. 2010年海晏县(0~14)岁健康人群百日咳、白喉、破伤风抗体水平调查[J].青海医药杂志,2013,43(1):66-67.
[18]李端,张志红.少数民族学生麻疹、白喉、百日咳、破伤风抗体水平检测分析[J].中国卫生检验杂志,2013,23(06):1555-1556.
[19]窦凤丽,石磊. 2013年襄州区儿童11种疫苗抗体检测结果分析[J].河南预防医学杂志,2014,25(1):70-71.
[20]崔鹏.银川市主要疫苗针对传染病流行特征及相关抗体水平调查研究[D].银川:宁夏医科大学,2015.
[21]王曙凌,王浩杰.内蒙古乌海市健康人群国家免疫规划疫苗抗体水平监测分析[J].医学动物防制,2017,33(4):415-417.
[22]李家学,刘圣,谭学凤.连云港市赣榆区1~10岁健康儿童流行性脑脊髓膜炎A、C群、百日咳、白喉、破伤风抗体水平的监测[J].现代预防医学,2016,43(18):3332-3334.
[23]武振军,胡皓,李燕,等.银川市0~7岁流动儿童8种传染病血清抗体水平监测分析[J].海南医学,2016,27(10): 1701-1703. DOI: 10.3969/j.issn.1003-6350.2016.10.054.
[24]张静朝.天峻县(0~14)岁儿童免疫抗体水平监测分析[J].青海医药杂志,2017,47(6):67-68.
[25]郝士卿,尤雯雯,刘晴,等.河北省辛集市未成年人百日咳、白喉和破伤风IgG抗体水平定量调查分析[J].医学动物防制,2018,34(3):283-284+287.
[26]佟立波,王友豪,车吉泊,等.某部2016年新兵破伤风抗体水平流行病学调查[J].中国疫苗和免疫,2018,24(1):53-56.
[27]张春焕,伍业健,贺晴.广州市2016年人群破伤风抗体水平监测结果分析[J].热带医学杂志,2018,18(9):1242-1245. DOI: 10.3969/j.issn.1672-3619.2018.09.030.
[28]许楠楠.山东省成人破伤风临床特点及人群破伤风抗体水平检测研究[D].济南:山东大学,2018.
[29]LiangJL, TiwariT, MoroP, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the advisory committee on immunization practices (ACIP)[J]. MMWR Recomm Rep, 2018, 67(2):1-44. DOI: 10.15585/mmwr.rr6702a1.
[30]麦浩,刘颖,龙虎,等. 2015—2017年桂林市全人群破伤风流行特征调查[J].中国急救复苏与灾害医学杂志,2018,13(11):1084-1086. DOI: 10.3969/j.issn.1673-6966.2018.11.013.
[31]黄文标.永城市2~39岁健康人群百日咳、白喉、破伤风抗体水平监测分析[J].疾病监测,2002,17(5):182-183. DOI: 10.3784/j.issn.1003-9961.2002.05.017.
[32]陆健,赵洁,姚健.崇明县健康人群百口咳、白喉、破伤风抗体水平监测分析[J].中国当代医药,2010,17(5):119-120. DOI: 10.3969/j.issn.1674-4721.2010.05.086.
[33]Borella-VenturiniM, FrassonC, PaluanF, et al. Tetanus accination, antibody persistence and decennial booster: a serosurvey of university students and at risk workers[J]. Epidemiol Infect, 2017, 145(9): 1757-1762. DOI: 10.1017/S0950268817000516.
[34]Tetanus vaccines: WHO position paper-February 2017[J]. Wkly Epidemiol Rec, 2017, 92(6): 53-76.
[35]LevineüL, EdsallG.Tetanus toxoid: what determines reaction proneness?[J].J Infect Dis, 1981,144(4):376. DOI: 10.1093/infdis/144.4.376.
[36]CollierLH, PolakoffS, MortimerJ. Reactions and antibody responses to reinforcing doses of adsorbed and plain tetanus vaccines[J].Lancet,1979,1(8131):1364-1368. DOI: 10.1016/s0140-6736(79)92006-3.

用户评论 0条

用户名: 密码: 登陆 注册
 
  • 9
  • 3
  •  4 : 页次:0/0页 共0条记录 5条/每页
    关于我们 | 专家风采 | 会员注册 | 继续教育
    地 址:北京市西城区东河沿街69号正弘大厦511室 邮 编:100052
    电话:010-51322302
    版权所有 中华医学会及中华预防医学杂志编辑部
    京ICP备 07035254 号